Table 3.
Rivaroxaban dosing [modified from Young et al. (16) and Rivaroxaban package insert].
| Dosing | ||
|---|---|---|
| Treatment dosing (after completion of 5 days of parenteral treatment) | Weight (kg) | Dose (mg) |
| 2.6–2.9 | 0.8 TID | |
| 3–3.9 | 0.9 TID | |
| 4–4.9 | 1.4 TID | |
| 5–6.9 | 1.6 TID | |
| 7–7.9 | 1.8 TID | |
| 8–8.9 | 2.4 TID | |
| 9–9.9 | 2.8 TID | |
| 10–11.9 | 3 TID | |
| 12–29.9 | 5 BID | |
| 30–49.9 | 15 OD | |
| ≥50 | 20 OD | |
| Thromboprophylaxis dosing | Weight (kg) | Dose (mg) |
| 7–7.9 | 1.1 BID | |
| 8–9.9 | 1.6 BID | |
| 10–11.9 | 1.7 BID | |
| 12–19.9 | 2 BID | |
| 20–29.9 | 2.5 BID | |
| 30–49.9 | 7.5 OD | |
| ≥50 | 10 OD |
BID, twice a day; OD, once a day; TID, three times a day.